Zoetis Inc. (ZTS)

NYSE: ZTS · IEX Real-Time Price · USD
174.61
+5.44 (3.22%)
Jun 24, 2022 4:07 PM EDT - Market closed
3.22%
Market Cap 82.18B
Revenue (ttm) 7.89B
Net Income (ttm) 2.07B
Shares Out 470.63M
EPS (ttm) 4.36
PE Ratio 40.06
Forward PE 32.05
Dividend $1.15 (0.66%)
Ex-Dividend Date Jul 20, 2022
Volume 3,255,000
Open 172.00
Previous Close 169.17
Day's Range 171.39 - 174.68
52-Week Range 154.18 - 249.27
Beta 0.77
Analysts Buy
Price Target 246.74 (+41.3%)
Earnings Date Aug 4, 2022

About ZTS

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives... [Read more...]

Industry Pharmaceuticals
IPO Date Feb 1, 2013
CEO Kristin Peck
Employees 12,100
Stock Exchange NYSE
Ticker Symbol ZTS
Full Company Profile

Financial Performance

In 2021, Zoetis's revenue was $7.78 billion, an increase of 16.49% compared to the previous year's $6.68 billion. Earnings were $2.04 billion, an increase of 24.36%.

Financial Statements

Analyst Forecast

According to 20 analysts, the average rating for ZTS stock is "Buy." The 12-month stock price forecast is 246.74, which is an increase of 41.31% from the latest price.

Price Target
$246.74
(41.31% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Final Trades: Zoetis, ChargePoint, Thermo Fisher & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other symbols: CHPTTMOXLE

Zoetis Completes Acquisition of Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Pr...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. today announced the completion of its acquisition of Basepaws.

Is There A Better Pick Over Merck Stock In Animal Health Space?

There is more to the comparison, and in the sections below, we discuss why we believe that ZTS stock will offer better returns than MRK stock in the next three years.

Other symbols: MRK

ASRT vs. ZTS: Which Stock Is the Better Value Option?

ASRT vs. ZTS: Which Stock Is the Better Value Option?

Other symbols: ASRT

Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13, 2022. Wetteny Joseph, Executive Vice Presiden...

Zoetis Releases 2021 Sustainability Update to Share Progress in Championing Healthier Communities, Animals and the Pl...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis published its 2021 Sustainability Progress update.

Zoetis Announces Agreement to Acquire Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio...

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. today announced an agreement to acquire Basepaws, a privately held petcare genetics company.

2 Stocks Down 29% or More to Buy and Hold Forever

Both of these companies are leaders in their industries.

Other symbols: MTCH

Final Trades: Zoetis, Costco, Disney & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other symbols: COSTDISBBOVV

Zoetis to Participate in the Stifel 2022 Jaws and Paws Conference

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2022 Jaws and Paws Conference on Wednesday, June 1, 2022. Glenn David, Executive Vice Pres...

ASRT vs. ZTS: Which Stock Should Value Investors Buy Now?

ASRT vs. ZTS: Which Stock Is the Better Value Option?

Other symbols: ASRT

Zoetis Declares Third Quarter 2022 Dividend

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.325 per share for the third quarter of 2022. The dividend will be...

Vanguard Health Care Fund's Top 5 Trades in the 1st Quarter

The Vanguard Health Care Fund (Trades, Portfolio) recently disclosed its first quarter 2022 portfolio, revealing that its top five trades for the quarter included a new position in Zoetis Inc. ( ZTS , F...

Other symbols: ANTMBMYELAN

7 Defensive Dividend Healthcare Stocks to Buy Now

As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. The post 7 Defensive Dividend Healthcare Stocks to Buy Now appeared first o...

Other symbols: ABBVAMGNBAXDGXHUMMRK

Zoetis' (ZTS) Q1 Earnings and Revenues Surpass Estimates

Zoetis' (ZTS) earnings and revenues trump estimates in the first quarter of 2022.

Zoetis (ZTS) Tops Q1 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 8.20% and 0.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zoetis Delivers First-Quarter Beat, But Guidance Takes An Unexpected Hit

Zoetis beat first-quarter expectations Thursday and ZTS stock rose higher despite the company's unexpected guidance cut. The post Zoetis Delivers First-Quarter Beat, But Guidance Takes An Unexpected Hit...

Zoetis Announces First Quarter 2022 Results

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Fortune500--Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2022 and updated its guidance for full year 2022 due to the ...

Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More

Let's look at the five biotech/drug companies, slated to release quarterly results on May 5.

Other symbols: ENDPNTLAVIRVRTX

Final Trades: Zoetis, Occidental, Paramount & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other symbols: OXYGDXPARA

Is a Beat in Store for Zoetis (ZTS) This Earnings Season?

Zoetis (ZTS) is set to report earnings and revenue figures and provide updates on its pipeline when it releases first-quarter 2022 results.

Zoetis (ZTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why the Earnings Surprise Streak Could Continue for Zoetis (ZTS)

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zoetis Foundation Announces First Round of 2022 Grants to Advance Farmer and Veterinarian Education, Livelihoods and ...

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DrivenToCare--Today, the Zoetis Foundation announced that it will distribute $4.9 million during its first round of 2022 grants, supporting 20 initiatives bas...

COLL or ZTS: Which Is the Better Value Stock Right Now?

COLL vs. ZTS: Which Stock Is the Better Value Option?

Other symbols: COLL